Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy
- PMID: 40873434
- PMCID: PMC12378905
- DOI: 10.3389/fbioe.2025.1498141
Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy
Abstract
Cell culture is a crucial technology in life science research, particularly in cancer studies. The morphology and biological properties of tumor cells, along with the mechanisms of tumor development, are highly dependent on their culture conditions. Antitumor drug sensitivity testing is essential for cancer treatment, helping to identify effective therapies and reduce patient treatment burden. Currently, 2D cell culture remains the primary method for antitumor drug sensitivity testing due to its cost-effectiveness, ease of operation, and high-throughput screening capability. However, it does not accurately replicate the tumor microenvironment. Animal models are important tools for drug development, but they are not suitable for high-throughput screening. Recent advancements in 3D culture technologies have addressed this limitation. These technologies can better mimic the tumor microenvironment and can accurately reflect tumor biological behavior, gene expression, and signaling pathways. This paper summarizes the current in vitro and in vivo culture models, discusses emerging three-dimensional cell culture technologies, and highlights their ability to effectively simulate the tumor microenvironment and their significant potential in drug sensitivity testing.
Keywords: 3D cell culture; drug screening; drug sensitivity testing; organoids; tumor microenvironment.
Copyright © 2025 Zhou, Yu, Guo, Tang and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients.bioRxiv [Preprint]. 2025 May 2:2024.06.28.601283. doi: 10.1101/2024.06.28.601283. bioRxiv. 2025. PMID: 40654830 Free PMC article. Preprint.
-
Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer.J Transl Med. 2025 Jul 16;23(1):798. doi: 10.1186/s12967-025-06824-5. J Transl Med. 2025. PMID: 40671128 Free PMC article. Review.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
References
-
- Abd El-Sadek I., Morishita R., Mori T., Makita S., Mukherjee P., Matsusaka S., et al. (2024). Label-free visualization and quantification of the drug-type-dependent response of tumor spheroids by dynamic optical coherence tomography. Sci. Rep. 14 (1), 3366. 10.1038/s41598-024-53171-4 - DOI - PMC - PubMed
-
- Ackermann M., Saleh F., Abdin S. M., Rafiei Hashtchin A., Gensch I., Golgath J., et al. (2024). Standardized generation of human iPSC-derived hematopoietic organoids and macrophages utilizing a benchtop bioreactor platform under fully defined conditions. Stem Cell Res. Ther. 15 (1), 171. 10.1186/s13287-024-03785-2 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous